| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 10 |
| 1 | METHOTREXATE | 9 |
| 2 | INFLIXIMAB | 5 |
| 3 | COPPER | 3 |
| 4 | CYCLOPHOSPHAMIDE | 3 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 7 | DOXORUBICIN | 3 |
| 8 | GEMCITABINE | 3 |
| 9 | GEMCITABINE HYDROCHLORIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 1 | LEMBOREXANT | 1 | 0.0003 |
| 2 | DECITABINE | 1 | 0.0002 |
| 3 | CARMUSTINE | 1 | 0.0002 |
| 4 | AVACOPAN | 1 | 0.0001 |
| 5 | VINORELBINE | 1 | 0.0001 |
| 6 | DACARBAZINE | 1 | 0.0001 |
| 7 | REPAGLINIDE | 1 | 0.0001 |
| 8 | ATOVAQUONE | 1 | 0.0001 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Glinide [EPC] | 1 | 0.0001 |
| 2 | Antimalarial [EPC] | 1 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 5 | Copper-containing Intrauterine Device [EPC] | 3 | 0.0001 |
| 6 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 9 | Antirheumatic Agent [EPC] | 2 | 0.0000 |